A. Sola‐Gazagnes

959 total citations
22 papers, 398 citations indexed

About

A. Sola‐Gazagnes is a scholar working on Endocrinology, Diabetes and Metabolism, Genetics and Surgery. According to data from OpenAlex, A. Sola‐Gazagnes has authored 22 papers receiving a total of 398 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Endocrinology, Diabetes and Metabolism, 8 papers in Genetics and 6 papers in Surgery. Recurrent topics in A. Sola‐Gazagnes's work include Diabetes Management and Research (15 papers), Diabetes Treatment and Management (8 papers) and Diabetes and associated disorders (7 papers). A. Sola‐Gazagnes is often cited by papers focused on Diabetes Management and Research (15 papers), Diabetes Treatment and Management (8 papers) and Diabetes and associated disorders (7 papers). A. Sola‐Gazagnes collaborates with scholars based in France, Belgium and Italy. A. Sola‐Gazagnes's co-authors include Étienne Larger, David Kerr, Elisabetta Torlone, Philip Home, Geremia B. Bolli, Ester Vitacolonna, G. Slama, Nadia Tubiana‐Rufi, Pauline Schaepelynck and Alfred Penfornis and has published in prestigious journals such as Diabetes Care, Diabetologia and Diabetes Obesity and Metabolism.

In The Last Decade

A. Sola‐Gazagnes

21 papers receiving 378 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
A. Sola‐Gazagnes France 12 298 170 152 40 32 22 398
Karin Kanc Slovenia 11 460 1.5× 159 0.9× 119 0.8× 35 0.9× 20 0.6× 17 569
Mary Halvorson United States 14 737 2.5× 441 2.6× 384 2.5× 62 1.6× 54 1.7× 20 869
Peter Lynch United States 12 280 0.9× 106 0.6× 117 0.8× 7 0.2× 31 1.0× 31 391
Ferdinand E E Van Der Does Netherlands 4 237 0.8× 56 0.3× 25 0.2× 33 0.8× 30 0.9× 4 332
Stéphanie Woerner United States 9 632 2.1× 334 2.0× 346 2.3× 50 1.3× 49 1.5× 15 773
Rubin Pooni Canada 6 189 0.6× 126 0.7× 91 0.6× 67 1.7× 33 1.0× 12 327
Carmen Mazza Argentina 12 187 0.6× 102 0.6× 193 1.3× 29 0.7× 27 0.8× 24 392
L A Gonder-Frederick United States 7 500 1.7× 204 1.2× 249 1.6× 24 0.6× 14 0.4× 8 560
Bernd Kulzer Germany 11 233 0.8× 39 0.2× 41 0.3× 11 0.3× 23 0.7× 21 294
Graham R. Law United Kingdom 8 282 0.9× 177 1.0× 116 0.8× 17 0.4× 15 0.5× 13 441

Countries citing papers authored by A. Sola‐Gazagnes

Since Specialization
Citations

This map shows the geographic impact of A. Sola‐Gazagnes's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A. Sola‐Gazagnes with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A. Sola‐Gazagnes more than expected).

Fields of papers citing papers by A. Sola‐Gazagnes

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A. Sola‐Gazagnes. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A. Sola‐Gazagnes. The network helps show where A. Sola‐Gazagnes may publish in the future.

Co-authorship network of co-authors of A. Sola‐Gazagnes

This figure shows the co-authorship network connecting the top 25 collaborators of A. Sola‐Gazagnes. A scholar is included among the top collaborators of A. Sola‐Gazagnes based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A. Sola‐Gazagnes. A. Sola‐Gazagnes is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Diedisheim, Marc, Catherine Pecquet, Jean‐Baptiste Julla, et al.. (2023). Prevalence and Description of the Skin Reactions Associated with Adhesives in Diabetes Technology Devices in an Adult Population: Results of the CUTADIAB Study. Diabetes Technology & Therapeutics. 25(4). 279–286. 13 indexed citations
2.
Sola‐Gazagnes, A., Catherine Pecquet, Stefano Berrè, et al.. (2022). Insulin allergy: a diagnostic and therapeutic strategy based on a retrospective cohort and a case–control study. Diabetologia. 65(8). 1278–1290. 8 indexed citations
3.
Moser, Othmar, Max L. Eckstein, Agnieszka Szadkowska, et al.. (2021). Performance of intermittently scanned continuous glucose monitoring systems in people with type 1 diabetes: A pooled analysis. Diabetes Obesity and Metabolism. 24(3). 522–529. 13 indexed citations
4.
Sola‐Gazagnes, A., Pauline Faucher, Sophie Jacqueminet, et al.. (2019). Disagreement between capillary blood glucose and flash glucose monitoring sensor can lead to inadequate treatment adjustments during pregnancy. Diabetes & Metabolism. 46(2). 158–163. 15 indexed citations
5.
6.
Larger, Étienne, et al.. (2018). [Diagnostic circumstances and clinical forms of type 1 diabetes].. PubMed. 68(6). 614–618. 1 indexed citations
7.
Consoli, Silla M., Raphaël Le Bouc, A. Sola‐Gazagnes, et al.. (2016). Delay discounting of gains and losses, glycemic control and therapeutic adherence in type 2 diabetes. Behavioural Processes. 132. 42–48. 44 indexed citations
8.
Joubert, Michaël, S. Baillot-Rudoni, Bogdan Catargi, et al.. (2015). Indication, organization, practical implementation and interpretation guidelines for retrospective CGM recording: A French position statement. Diabetes & Metabolism. 41(6). 498–508. 14 indexed citations
9.
Schaepelynck, Pauline, Éric Renard, H. Hanaire, et al.. (2014). Assessment of a New Insulin Preparation for Implanted Pumps Used in the Treatment of Type 1 Diabetes. Diabetes Technology & Therapeutics. 16(9). 582–589. 9 indexed citations
10.
Sola‐Gazagnes, A., et al.. (2013). Effect of dietary protein on post‐prandial glucose in patients with type 1 diabetes. Journal of Human Nutrition and Dietetics. 26(6). 606–611. 16 indexed citations
11.
Lormeau, B., et al.. (2013). P2006 Intérêt d’un mélange suroxygéné (Nitrox) en plongée sous marine chez le patient diabétique de type 1. Diabetes & Metabolism. 39. A70–A71. 1 indexed citations
12.
Pecquet, C., et al.. (2012). Continuous subcutaneous insulin infusion allows tolerance induction and diabetes treatment in a type 1 diabetic child with insulin allergy. Diabetes & Metabolism. 39(2). 174–177. 16 indexed citations
13.
Benhamou, Pierre‐Yves, Bogdan Catargi, Bruno Guerci, et al.. (2012). Real-time continuous glucose monitoring (CGM) integrated into the treatment of type 1 diabetes: Consensus of experts from SFD, EVADIAC and SFE. Diabetes & Metabolism. 38. S67–S83. 30 indexed citations
14.
Sola‐Gazagnes, A. & Jean‐Pierre Riveline. (2012). La mesure continue du glucose : présent et avenir Mesure continue du glucose au long cours en 2012. Médecine des Maladies Métaboliques. 6(6). 484–489.
15.
Sola‐Gazagnes, A., et al.. (2011). Emergent technologies applied to diabetes: What do we need to integrate continuous glucose monitoring into daily practice?. Diabetes & Metabolism. 37. S65–S70. 3 indexed citations
16.
Sola‐Gazagnes, A., J. M’Bemba, Christian Boîtard, et al.. (2011). Ambulatory 24-hour fast using flexible insulin therapy in patients with type 1 diabetes. Diabetes & Metabolism. 37(6). 553–559. 3 indexed citations
17.
Lemogne, Cédric, A. Sola‐Gazagnes, Nicole Guédeney, et al.. (2010). Therapeutic alliance and glycaemic control in type 1 diabetes: A pilot study. Diabetes & Metabolism. 36(6). 499–502. 15 indexed citations
18.
Daenen, Simon, A. Sola‐Gazagnes, J. M’Bemba, et al.. (2010). Peak-time determination of post-meal glucose excursions in insulin-treated diabetic patients. Diabetes & Metabolism. 36(2). 165–169. 38 indexed citations
19.
Bolli, Geremia B., David Kerr, Elisabetta Torlone, et al.. (2009). Comparison of a Multiple Daily Insulin Injection Regimen (Basal Once-Daily Glargine Plus Mealtime Lispro) and Continuous Subcutaneous Insulin Infusion (Lispro) in Type 1 Diabetes. Diabetes Care. 32(7). 1170–1176. 85 indexed citations
20.
Sola‐Gazagnes, A.. (2008). Les allergies à l’insuline. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Karin Kanc Breakdown of academic impact, for papers by Mary Halvorson Breakdown of academic impact, for papers by Peter Lynch Breakdown of academic impact, for papers by Ferdinand E E Van Der Does Breakdown of academic impact, for papers by Stéphanie Woerner Breakdown of academic impact, for papers by Rubin Pooni Breakdown of academic impact, for papers by Carmen Mazza Breakdown of academic impact, for papers by L A Gonder-Frederick Breakdown of academic impact, for papers by Bernd Kulzer Breakdown of academic impact, for papers by Graham R. Law
Rankless by CCL
2026